q2 abbott laboratories

News

Abbott Laboratories, The Q2 and Earnings Call

Abbott Laboratories (NYSE:ABT) Q2 2025 Earnings Call Transcript

Q2 2025 Earnings Call Transcript July 17, 2025 Abbott Laboratories reports earnings inline with expectations. Reported EPS is $1.26 EPS, expectations were $1.26. Operator: Good morning, and thank you for standing by.

Yahoo Finance · 1d

Abbott Laboratories (ABT) Q2 2025 Earnings Call Highlights: Strong Growth in Medical Devices ...

Abbott Laboratories (ABT) reports robust earnings growth and margin expansion, driven by medical devices, despite headwinds in diagnostics and international markets.

Seeking Alpha · 1d

Abbott Laboratories: What's Behind The Q2 Earnings Slump?

Abbott Laboratories' second-largest division, diagnostics, continues to be a hindrance, while the FY group operating margin guidance was cut. Learn more on ABT stock here.

2don MSN

Abbott Laboratories falls after setting Q3 outlook below consensus

Shares of Abbott Laboratories (NYSE:ABT) lost ~5% in the premarket on Thursday after the MedTech company provided its ...

These Analysts Revise Their Forecasts On Abbott Following Q2 Results

Abbott forecasts an adjusted operating margin of approximately 23.5% of sales, down from prior guidance of 23.5%- 24.0%.

BioWorld2d

Abbott med tech bumps up Q2 results

Abbott Laboratories’ second quarter results echoed Johnson & Johnson’s, with med tech performing the hero’s work with strong growth. Overall, Abbott slightly beat expectations with sales up 6.9% ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results